LifeAhead provides personalized reproductive health forecasting that predicts an individual's fertility and menopause timelines using routine clinical measurements like ultrasound data and bloodwork. Built on a peer-reviewed stochastic mathematical model of ovarian follicle depletion, the platform generates individualized probability-based projections rather than population averages. The HIPAA-compliant tool is designed for integration into clinical workflows, helping patients and healthcare providers make informed family planning decisions.
Funding
Funding not disclosed
Founders
Product
Problem
Women face significant uncertainty about their reproductive timelines, often relying on population averages or family history that may not reflect their individual biology. This lack of personalized information makes it difficult to make informed decisions about family planning, career timing, and fertility preservation options, particularly for those concerned about early menopause or age-related fertility decline.
Solution
LifeAhead provides a computational forecasting platform that generates personalized projections of reproductive milestones, including fertility and menopause timelines, years in advance. The technology uses a novel stochastic mathematical model of ovarian follicle depletion, developed at a university and published in Science Advances, to analyze routine clinical biomarkers such as anti-Müllerian hormone (AMH) and antral follicle count (AFC). By inputting basic personal information, ultrasound data, and bloodwork, patients receive individualized probability-based forecasts rather than generic population averages. The platform is designed for straightforward integration into clinical workflows, allowing healthcare providers to interpret results with patients and guide them in making evidence-based reproductive health decisions.
Target Audience
Primary users are women seeking clarity about their reproductive timelines, particularly those concerned about early menopause or fertility planning, as well as healthcare professionals including OB/GYNs and fertility specialists who want to offer personalized forecasting to their patients.
Features
- Personalized forecasting of fertility and menopause timelines based on individual clinical biomarkers (AMH, AFC) rather than population averages
- Stochastic mathematical model of ovarian follicle depletion published in Science Advances (AAAS)
- Inputs include routine clinical measurements: personal information, ultrasound data, and bloodwork
- HIPAA-compliant platform designed for clinical workflow integration
- Probability-based predictions that quantify uncertainty and provide individualized risk assessment
- Interpretable results designed for clinician-guided patient counseling and family planning discussions